Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1283

1.

Following the Status of Visual Cortex Over Time in Patients With Macular Degeneration Reveals Atrophy of Visually Deprived Brain Regions.

Hanson RLW, Gale RP, Gouws AD, Airody A, Scott MTW, Akthar F, Waterson S, Wells MT, Wright AJ, Bell K, Silson E, Baseler HA, Morland AB.

Invest Ophthalmol Vis Sci. 2019 Dec 2;60(15):5045-5051. doi: 10.1167/iovs.18-25823.

PMID:
31800962
2.

Variables associated with patient-reported symptoms in persons with chronic phase chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy.

Yu L, Huang X, Gale RP, Wang H, Jiang Q.

Medicine (Baltimore). 2019 Nov;98(48):e18079. doi: 10.1097/MD.0000000000018079.

3.

Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset.

Monés J, Singh RP, Bandello F, Souied E, Liu X, Gale R.

Ophthalmologica. 2019 Nov 19:1-8. doi: 10.1159/000502747. [Epub ahead of print] Review.

4.

Integrating Pediatric Care And Taking On Risk To Improve Health.

Gale R.

Health Aff (Millwood). 2019 Nov;38(11):1786-1790. doi: 10.1377/hlthaff.2019.01204.

PMID:
31682496
5.

Medical Record Documentation of Goals-of-Care Discussions Among Older Veterans With Incident Kidney Failure.

Bradshaw CL, Gale RC, Chettiar A, Ghaus SJ, Thomas IC, Fung E, Lorenz K, Asch SM, Anand S, Kurella Tamura M.

Am J Kidney Dis. 2019 Oct 31. pii: S0272-6386(19)31004-2. doi: 10.1053/j.ajkd.2019.07.024. [Epub ahead of print]

PMID:
31679746
6.

Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.

DeFilipp Z, Ancheta R, Liu Y, Hu ZH, Gale RP, Snyder D, Schouten HC, Kalaycio M, Hildebrandt GC, Ustun C, Daly A, Ganguly S, Inamoto Y, Litzow M, Szer J, Savoie ML, Hossain N, Kharfan-Dabaja MA, Hamadani M, Reshef R, Bajel A, Schultz KR, Gadalla S, Gerds A, Liesveld J, Juckett MB, Kamble R, Hashmi S, Abdel-Azim H, Solh M, Bacher U, Lazarus H, Olsson R, Cahn JY, Grunwald MR, Savani BN, Yared J, Rowe JM, Cerny J, Chaudhri NA, Aljurf M, Beitinjaneh A, Seo S, Nishihori T, Hsu JW, Ramanathan M, Alyea E, Popat U, Sobecks R, Saber W.

Biol Blood Marrow Transplant. 2019 Oct 25. pii: S1083-8791(19)30674-3. doi: 10.1016/j.bbmt.2019.10.017. [Epub ahead of print]

PMID:
31669399
7.

Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantation.

Othus M, Gale RP, Hourigan CS, Walter RB.

Bone Marrow Transplant. 2019 Oct 30. doi: 10.1038/s41409-019-0729-4. [Epub ahead of print]

PMID:
31666655
8.

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.

Bejanyan N, Kim S, Hebert KM, Kekre N, Abdel-Azim H, Ahmed I, Aljurf M, Badawy SM, Beitinjaneh A, Boelens JJ, Diaz MA, Dvorak CC, Gadalla S, Gajewski J, Gale RP, Ganguly S, Gennery AR, George B, Gergis U, Gómez-Almaguer D, Vicent MG, Hashem H, Kamble RT, Kasow KA, Lazarus HM, Mathews V, Orchard PJ, Pulsipher M, Ringden O, Schultz K, Teira P, Woolfrey AE, Saldaña BD, Savani B, Winiarski J, Yared J, Weisdorf DJ, Antin JH, Eapen M.

Blood Adv. 2019 Oct 22;3(20):3123-3131. doi: 10.1182/bloodadvances.2019000722.

9.

Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia.

Linch DC, Hills RK, Burnett AK, Russell N, Gale RE.

Br J Haematol. 2019 Oct 8. doi: 10.1111/bjh.16239. [Epub ahead of print]

PMID:
31595497
10.

Does a durian smell like a rose? The dangers of jargon.

Gale RP, Lazarus HM.

Bone Marrow Transplant. 2019 Sep 30. doi: 10.1038/s41409-019-0704-0. [Epub ahead of print] No abstract available.

PMID:
31570782
11.

John Hansen, MD : HLA Transplant Pioneer and Teacher, May 1, 1943 to July 31, 2019.

Gale RP.

Bone Marrow Transplant. 2019 Sep 30. doi: 10.1038/s41409-019-0709-8. [Epub ahead of print] No abstract available.

PMID:
31570778
12.

Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.

Zinter MS, Logan BR, Fretham C, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Gale RP, Guinan E, Hematti P, Keating AK, Marks DI, Olsson R, Savani BN, Ustun C, Williams KM, Pasquini MC, Dvorak CC.

Biol Blood Marrow Transplant. 2019 Sep 26. pii: S1083-8791(19)30638-X. doi: 10.1016/j.bbmt.2019.09.027. [Epub ahead of print]

PMID:
31563573
13.

Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation.

Sabloff M, Chhabra S, Wang T, Fretham C, Kekre N, Abraham A, Adekola K, Auletta JJ, Barker C, Beitinjaneh AM, Bredeson C, Cahn JY, Diaz MA, Freytes C, Gale RP, Ganguly S, Gergis U, Guinan E, Hamilton BK, Hashmi S, Hematti P, Hildebrandt G, Holmberg L, Hong S, Lazarus HM, Martino R, Muffly L, Nishihori T, Perales MA, Yared J, Mineishi S, Stadtmauer EA, Pasquini MC, Loren AW.

Biol Blood Marrow Transplant. 2019 Dec;25(12):2398-2407. doi: 10.1016/j.bbmt.2019.08.012. Epub 2019 Aug 29.

PMID:
31473319
14.

Controversies and challenges in HLA-haplotype-matched transplants for leukaemia.

Gale RP.

Bone Marrow Transplant. 2019 Aug;54(Suppl 2):719-720. doi: 10.1038/s41409-019-0611-4.

PMID:
31431720
15.

Emergency response to radiological and nuclear accidents and incidents.

Gale RP, Armitage JO, Hashmi SK.

Br J Haematol. 2019 Aug 6. doi: 10.1111/bjh.16138. [Epub ahead of print] Review.

PMID:
31388987
16.

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.

Gale RP, Pearce I, Eter N, Ghanchi F, Holz FG, Schmitz-Valckenberg S, Balaskas K, Burton BJL, Downes SM, Eleftheriadis H, George S, Gilmour D, Hamilton R, Lotery AJ, Patel N, Prakash P, Santiago C, Thomas S, Varma D, Walters G, Williams M, Wolf A, Zakri RH, Igwe F, Ayan F.

Br J Ophthalmol. 2019 Aug 5. pii: bjophthalmol-2019-314251. doi: 10.1136/bjophthalmol-2019-314251. [Epub ahead of print]

17.

Predicting the outcome of patients with chronic lymphocytic leukemia: Progress and uncertainty.

Montserrat E, Gale RP.

Cancer. 2019 Nov 1;125(21):3699-3705. doi: 10.1002/cncr.32353. Epub 2019 Aug 5.

PMID:
31381130
18.

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.

Kim HT, Ahn KW, Hu ZH, Davids MS, Volpe VO, Antin JH, Sorror ML, Shadman M, Press O, Pidala J, Hogan W, Negrin R, Devine S, Uberti J, Agura E, Nash R, Mehta J, McGuirk J, Forman S, Langston A, Giralt SA, Perales MA, Battiwalla M, Hale GA, Gale RP, Marks DI, Hamadani M, Ganguly S, Bacher U, Lazarus H, Reshef R, Hildebrandt GC, Inamoto Y, Cahn JY, Solh M, Kharfan-Dabaja MA, Ghosh N, Saad A, Aljurf M, Schouten HC, Hill BT, Pawarode A, Kindwall-Keller T, Saba N, Copelan EA, Nathan S, Beitinjaneh A, Savani BN, Cerny J, Grunwald MR, Yared J, Wirk BM, Nishihori T, Chhabra S, Olsson RF, Bashey A, Gergis U, Popat U, Sobecks R, Alyea E, Saber W, Brown JR.

Clin Cancer Res. 2019 Aug 15;25(16):5143-5155. doi: 10.1158/1078-0432.CCR-18-3988. Epub 2019 Jun 28.

PMID:
31253630
19.

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

Rashidi A, Hamadani M, Zhang MJ, Wang HL, Abdel-Azim H, Aljurf M, Assal A, Bajel A, Bashey A, Battiwalla M, Beitinjaneh AM, Bejanyan N, Bhatt VR, Bolaños-Meade J, Byrne M, Cahn JY, Cairo M, Ciurea S, Copelan E, Cutler C, Daly A, Diaz MA, Farhadfar N, Gale RP, Ganguly S, Grunwald MR, Hahn T, Hashmi S, Hildebrandt GC, Holland HK, Hossain N, Kanakry CG, Kharfan-Dabaja MA, Khera N, Koc Y, Lazarus HM, Lee JW, Maertens J, Martino R, McGuirk J, Munker R, Murthy HS, Nakamura R, Nathan S, Nishihori T, Palmisiano N, Patel S, Pidala J, Olin R, Olsson RF, Oran B, Ringden O, Rizzieri D, Rowe J, Savoie ML, Schultz KR, Seo S, Shaffer BC, Singh A, Solh M, Stockerl-Goldstein K, Verdonck LF, Wagner J, Waller EK, De Lima M, Sandmaier BM, Litzow M, Weisdorf D, Romee R, Saber W.

Blood Adv. 2019 Jun 25;3(12):1826-1836. doi: 10.1182/bloodadvances.2019000050.

20.

IL-22 Accelerates Thymus Regeneration via Stat3/Mcl-1 and Decreases Chronic Graft-versus-Host Disease in Mice after Allotransplants.

Pan B, Wang D, Li L, Shang L, Xia F, Zhang F, Zhang Y, Gale RP, Xu M, Li Z, Xu K.

Biol Blood Marrow Transplant. 2019 Oct;25(10):1911-1919. doi: 10.1016/j.bbmt.2019.06.002. Epub 2019 Jun 10.

PMID:
31195136
21.

Antiepileptic Effects of a Novel Non-invasive Neuromodulation Treatment in a Subject With Early-Onset Epileptic Encephalopathy: Case Report With 20 Sessions of HD-tDCS Intervention.

Meiron O, Gale R, Namestnic J, Bennet-Back O, Gebodh N, Esmaeilpour Z, Mandzhiyev V, Bikson M.

Front Neurosci. 2019 May 29;13:547. doi: 10.3389/fnins.2019.00547. eCollection 2019.

22.

Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema.

Chakravarthy U, Pearce I, Banerjee S, Burton BJL, Downey L, Gale R, Patel J, Patra S, Sivaprasad S, Stevenson M, Lupton S.

BMJ Open Ophthalmol. 2019 Apr 30;4(1):e000226. doi: 10.1136/bmjophth-2018-000226. eCollection 2019.

23.

Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Hamilton BK, Liu Y, Hemmer MT, Majhail N, Ringden O, Kim D, Costa L, Stuart R, Alousi A, Pidala JA, Couriel DR, Aljurf M, Antin JH, Bredeson C, Cahn JY, Cairo M, Choi SW, Dandoy C, Gale RP, Gergis U, Hematti P, Inamoto Y, Kamble RT, MacMillan M, Marks DI, Nemecek E, Nishihori T, Saad A, Savani BN, Schriber J, Seo S, Socié G, Teshima T, Verdonck LF, Waller EK, Wirk M, Spellman SR, Arora M, Chhabra S.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1744-1755. doi: 10.1016/j.bbmt.2019.05.019. Epub 2019 May 31.

PMID:
31158502
24.

Chronic myeloid leukemia stem cells.

Houshmand M, Simonetti G, Circosta P, Gaidano V, Cignetti A, Martinelli G, Saglio G, Gale RP.

Leukemia. 2019 Jul;33(7):1543-1556. doi: 10.1038/s41375-019-0490-0. Epub 2019 May 24. Review.

25.

Cellular therapy for acute myeloid Leukemia - Current status and future prospects.

Hansrivijit P, Gale RP, Barrett J, Ciurea SO.

Blood Rev. 2019 Sep;37:100578. doi: 10.1016/j.blre.2019.05.002. Epub 2019 May 11. Review.

PMID:
31109711
26.

Post-transplant cyclophosphamide use in matched HLA donors: a review of literature and future application.

El Fakih R, Hashmi SK, Ciurea SO, Luznik L, Gale RP, Aljurf M.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0547-8. [Epub ahead of print] Review.

PMID:
31089284
27.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.

Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J, Gale RP, Gandhi M, Gergis U, Hamilton BK, Hematti P, Hildebrandt GC, Kamble RT, Kanate AS, Khandelwal P, Lazaryan A, MacMillan M, Marks DI, Martino R, Mehta PA, Nishihori T, Olsson RF, Patel SS, Qayed M, Rangarajan HG, Reshef R, Ringden O, Savani BN, Schouten HC, Schultz KR, Seo S, Shaffer BC, Solh M, Teshima T, Urbano-Ispizua A, Verdonck LF, Vij R, Waller EK, William B, Wirk B, Yared JA, Yu LC, Arora M, Hashmi S.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1875-1883. doi: 10.1016/j.bbmt.2019.05.007. Epub 2019 May 11.

PMID:
31085303
28.

Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors.

Nteliopoulos G, Bazeos A, Claudiani S, Gerrard G, Curry E, Szydlo R, Alikian M, Foong HE, Nikolakopoulou Z, Loaiza S, Khorashad JS, Milojkovic D, Perrotti D, Gale RP, Foroni L, Apperley JF.

Haematologica. 2019 Dec;104(12):2400-2409. doi: 10.3324/haematol.2018.200220. Epub 2019 May 9.

29.

Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome.

Shi Z, Qin T, Xu Z, Li B, Huang H, Zhang H, Fang L, Pan L, Hu N, Qu S, Huang G, Gale RP, Xiao Z.

Leuk Lymphoma. 2019 Nov;60(11):2835-2837. doi: 10.1080/10428194.2019.1607324. Epub 2019 May 6. No abstract available.

PMID:
31056995
30.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Ahmed I, Aljurf M, Askar M, Auletta JJ, Bhatt V, Bredeson C, Chhabra S, Gadalla S, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Inamoto Y, Kitko C, Khandelwal P, MacMillan ML, Majhail N, Marks DI, Mehta P, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Qayed M, Rangarajan H, Ringden O, Saad A, Savani BN, Seo S, Shah A, Shah N, Schultz KR, Solh M, Spitzer T, Szer J, Teshima T, Verdonck LF, Williams KM, Wirk B, Wagner J, Yared JA, Weisdorf DJ.

Blood Adv. 2019 May 14;3(9):1441-1449. doi: 10.1182/bloodadvances.2018030171.

31.

Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia?

Saglio G, Fava C, Gale RP.

Haematologica. 2019 May;104(5):862-864. doi: 10.3324/haematol.2018.214445. No abstract available.

32.

Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study.

Kizilors A, Crisà E, Lea N, Passera R, Mian S, Anwar J, Best S, Nicolini FE, Ireland R, Aldouri M, Pocock C, Corbett T, Gale R, Bart-Smith E, Weston-Smith S, Wykes C, Kulasekararaj A, Jackson S, Harrington P, McLornan D, Raj K, Pagliuca A, Mufti GJ, de Lavallade H.

Lancet Haematol. 2019 May;6(5):e276-e284. doi: 10.1016/S2352-3026(19)30027-4.

PMID:
31036317
33.

CBeV (cyclophosphamide, bendamustine and etoposide) pre-autotransplant conditioning in persons with lymphoma.

Jaimovich G, Ostriz MBR, Castro M, Riera L, Foncuberta C, Longoni H, Cia A, Duarte P, Vitriu A, Lastiri F, Gale RP.

Bone Marrow Transplant. 2019 Apr 23. doi: 10.1038/s41409-019-0528-y. [Epub ahead of print] No abstract available.

PMID:
31015577
34.

Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non-frozen grafts in persons with multiple sclerosis.

Gale RP, Gómez-Cruz GB, Olivares-Gazca JC, León-Peña AA, Gómez-Almaguer D, Gómez-De-León A, González-López EE, Ruiz-Argüelles A, Soto-Vega E, Muñoz-Pérez MJ, Ruiz-Delgado GJ, Ruiz-Argüelles GJ.

Clin Transplant. 2019 Jun;33(6):e13567. doi: 10.1111/ctr.13567. Epub 2019 May 7.

PMID:
31004516
35.

Structure and mechanism of TagA, a novel membrane-associated glycosyltransferase that produces wall teichoic acids in pathogenic bacteria.

Kattke MD, Gosschalk JE, Martinez OE, Kumar G, Gale RT, Cascio D, Sawaya MR, Philips M, Brown ED, Clubb RT.

PLoS Pathog. 2019 Apr 19;15(4):e1007723. doi: 10.1371/journal.ppat.1007723. eCollection 2019 Apr.

36.

Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service.

Gale RP, Mahmood S, Devonport H, Patel PJ, Ross AH, Walters G, Downey L, El-Sherbiny S, Freeman M, Berry S, Jain N.

Eye (Lond). 2019 Mar;33(Suppl 1):1-21. doi: 10.1038/s41433-018-0300-3. Review.

37.

Causal inference in randomized clinical trials.

Zheng C, Dai R, Gale RP, Zhang MJ.

Bone Marrow Transplant. 2019 Mar 26. doi: 10.1038/s41409-018-0424-x. [Epub ahead of print] No abstract available.

PMID:
30914756
38.

Statistical analyses of clinical trials in haematopoietic cell transplantation or why there is a strong correlation between people drowning after falling out of a fishing boat and marriage rate in Kentucky.

Gale RP, Zhang MJ.

Bone Marrow Transplant. 2019 Mar 26. doi: 10.1038/s41409-019-0431-6. [Epub ahead of print] No abstract available.

PMID:
30914755
39.

Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant.

Parikh SH, Satwani P, Ahn KW, Sahr NA, Fretham C, Abraham AA, Agrawal V, Auletta JJ, Abdel-Azim H, Copelan E, Diaz MA, Dvorak CC, Frangoul HA, Freytes CO, Gadalla SM, Gale RP, George B, Gergis U, Hashmi S, Hematti P, Hildebrandt GC, Keating AK, Lazarus HM, Myers KC, Olsson RF, Prestidge T, Rotz SJ, Savani BN, Shereck EB, Williams KM, Wirk B, Pasquini MC, Loren AW.

JAMA Pediatr. 2019 May 1;173(5):e190081. doi: 10.1001/jamapediatrics.2019.0081. Epub 2019 May 6.

PMID:
30882883
40.

Response to the Commentary on "Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma".

Barosi G, Gale RP.

Leukemia. 2019 May;33(5):1301-1302. doi: 10.1038/s41375-019-0432-x. Epub 2019 Mar 6. No abstract available.

PMID:
30842607
41.

Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.

Shi Z, Li B, Huang H, Qin T, Xu Z, Zhang H, Fang L, Pan L, Hu N, Qu S, Huang G, Gale RP, Xiao Z.

Br J Haematol. 2019 Jul;186(2):352-355. doi: 10.1111/bjh.15830. Epub 2019 Mar 5. No abstract available.

PMID:
30836422
42.

For A Big-City Health Department, A New Focus On Health Equity.

Gale R.

Health Aff (Millwood). 2019 Mar;38(3):347-351. doi: 10.1377/hlthaff.2019.00150.

PMID:
30830805
43.

Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N.

Bone Marrow Transplant. 2019 May;54(5):782-783. doi: 10.1038/s41409-019-0472-x.

PMID:
30809032
44.

Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.

Kilari D, D'Souza A, Fraser R, Qayed M, Davila O, Agrawal V, Diaz MA, Chhabra S, Cerny J, Copelan E, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hildebrandt GC, Holmberg L, Kamble RT, Kapoor P, Lazarus H, Lee C, Murthy HS, Naik S, Nishihori T, Saad A, Savani BN, Seo S, Warwick A, Wirk B, Yared JA, Nieto Y, Hari P.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1099-1106. doi: 10.1016/j.bbmt.2019.02.015. Epub 2019 Feb 20.

PMID:
30794931
45.

Chronic myeloid leukemia: Two mysteries.

Radivoyevitch T, Jorgensen TN, Lindner DJ, Maciejewski JP, Miyazaki Y, Gale RP.

Leuk Res. 2019 Apr;79:3-5. doi: 10.1016/j.leukres.2019.02.003. Epub 2019 Feb 12. No abstract available.

PMID:
30780032
46.

Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration.

Gale RC, Wu J, Erhardt T, Bounthavong M, Reardon CM, Damschroder LJ, Midboe AM.

Implement Sci. 2019 Feb 1;14(1):11. doi: 10.1186/s13012-019-0853-y.

47.

Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study.

Abidi MZ, Hari P, Chen M, Kim S, Battiwala M, Dahi PB, Diaz MA, Gale RP, Ganguly S, Gergis U, Green J, Hildebrandt G, Hill JA, Komanduri K, Lazarus H, Marks D, Nishihori T, Olsson R, Seo S, Ustun C, Yared J, Yin D, Wingard J, Wirk BM, Auletta J, Lindemans C, Riches M.

Bone Marrow Transplant. 2019 Aug;54(8):1354-1360. doi: 10.1038/s41409-019-0457-9. Epub 2019 Jan 29.

PMID:
30696997
48.

Is lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma?

Barosi G, Gale RP.

Leukemia. 2019 Mar;33(3):588-596. doi: 10.1038/s41375-019-0383-2. Epub 2019 Jan 28. Review.

PMID:
30692596
49.

New study-designs to address the clinical complexity of acute myeloid leukemia.

Estey E, Othus M, Gale RP.

Leukemia. 2019 Mar;33(3):567-569. doi: 10.1038/s41375-018-0363-y. Epub 2019 Jan 22. No abstract available.

PMID:
30670784
50.

Prof. Franco Mandelli Leukaemia Visionary. May 12, 1931- July 15, 2018.

Amadori S, Arcese W, Avvisati G, Gale RP, Lo-Coco F.

Leukemia. 2019 Feb;33(2):285-286. doi: 10.1038/s41375-018-0352-1. No abstract available.

Supplemental Content

Support Center